These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


302 related items for PubMed ID: 11852379

  • 1. Insulin therapy may increase blood pressure levels in type 2 diabetes mellitus.
    Kanoun F, Ben Amor Z, Zouari B, Ben Khalifa F.
    Diabetes Metab; 2001 Dec; 27(6):695-700. PubMed ID: 11852379
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 3. [Hypertension and insulin treatment in type 2 diabetes].
    Ben Salem Hachmi L, Bouguerra R, Maatki O, Smadhi H, Turki Z, Hraoui S, Ben Slama C.
    Arch Mal Coeur Vaiss; 2007 Aug; 100(8):664-7. PubMed ID: 17928772
    [Abstract] [Full Text] [Related]

  • 4. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S, Estacio RO, Jeffers B, Schrier RW.
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [Abstract] [Full Text] [Related]

  • 5. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO, Jeffers BW, Gifford N, Schrier RW.
    Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [Abstract] [Full Text] [Related]

  • 6. [Development of blood pressure level over a three years period in non-insulin dependent diabetic subjects according to their microalbuminuria].
    Mayaudon H, Bauduceau B, Ducorps M, Belmejdoub G, Poirier JM.
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1045-9. PubMed ID: 8949376
    [Abstract] [Full Text] [Related]

  • 7. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
    Rostaing L, Moreau-Gaudry X, Baron E, Cisterne JM, Monroziès-Bernadet P, Durand D.
    Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
    [Abstract] [Full Text] [Related]

  • 8. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Henricsson M, Nilsson A, Janzon L, Groop L.
    Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 10. [Clinical characteristics and outcome of adult diabetic patients with ketosis as the initial manifestation: a follow-up study].
    Cai XL, Ji LN.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 May; 16(5):299-302. PubMed ID: 15132798
    [Abstract] [Full Text] [Related]

  • 11. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
    Derosa G, D'Angelo A, Salvadeo SA, Ferrari I, Gravina A, Fogari E, Maffioli P, Cicero AF.
    Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
    [Abstract] [Full Text] [Related]

  • 12. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS, Aslam M, Naveed AK, Razi MS.
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [Abstract] [Full Text] [Related]

  • 13. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ, Goldenberg N, Sieve L, Wang P.
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [Abstract] [Full Text] [Related]

  • 14. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK, Bhansali A, Sialy R, Malhotra S, Pandhi P.
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [Abstract] [Full Text] [Related]

  • 15. Adiponectin--insulin and resistin plasma levels in young healthy offspring of patients with essential hypertension.
    Papadopoulos DP, Makris TK, Perrea D, Papazachou O, Daskalaki M, Sanidas E, Votteas V.
    Blood Press; 2008 Dec; 17(1):50-4. PubMed ID: 18568692
    [Abstract] [Full Text] [Related]

  • 16. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
    Chazova I, Almazov VA, Shlyakhto E.
    Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
    [Abstract] [Full Text] [Related]

  • 17. Hypertension and related risk factors in type 2 diabetes mellitus.
    Lunetta M, Barbagallo A, Crimi S, Di Mauro M, Sangiorgio L, Mughini L.
    Minerva Endocrinol; 1999 Jun; 24(2):45-50. PubMed ID: 10941422
    [Abstract] [Full Text] [Related]

  • 18. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
    Derosa G, Cicero AF, Murdolo G, Ciccarelli L, Fogari R.
    Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
    [Abstract] [Full Text] [Related]

  • 19. [Modifications of 24-h blood pressure profile associated with reduction of the heart rate variability in type 1 diabetic patients].
    Garcia C, Mayaudon H, Bordier L, Le Berre JP, Dupuy O, Bauduceau B.
    Arch Mal Coeur Vaiss; 2007 Aug; 100(8):699-703. PubMed ID: 17928780
    [Abstract] [Full Text] [Related]

  • 20. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C, Melbourne Diabetic Nephropathy Study Group.
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.